←
Sylvan Baca MD PhD (Hiring!)154 posts
Sylvan Baca MD PhD (Hiring!) avatar✓

Sylvan Baca MD PhD (Hiring!) ✓

@SylvanBacaLab

Genitourinary oncologist running a computational epigenomics lab @DanaFarber, Assistant Professor @harvardmed

◷ Joined June 2022▧ 47 Photos and videos
Sylvan Baca MD PhD (Hiring!) avatar
Sylvan Baca MD PhD (Hiring!)@SylvanBacaLab·Oct 29

Integrating cfcQTLs with genetic association studies linked 4,891 loci to 1,011 traits and diseases, with some examples here. Developmentally restricted regulatory elements were especially rich in trait associations.

Post attachment
Sylvan Baca MD PhD (Hiring!) avatar
Sylvan Baca MD PhD (Hiring!)@SylvanBacaLab·Oct 29

A neat finding: circulating chromatin also exposed genetic effects on developmental regulatory elements that are reactivated in cancer and hard to sample in adult tissues. cfcQTLs in our cohort were enriched ~16-fold in developmental regulatory elements.

Post attachment
Sylvan Baca MD PhD (Hiring!) avatar
Sylvan Baca MD PhD (Hiring!)@SylvanBacaLab·Oct 29

For example, here are chromatin QTLs at risk loci for prostate cancer and kidney cancer. They affect regulatory elements that aren't active in blood cells due to lineage restriction, but are easy to measure in cfChIP data from patients with cancer.

Post attachment
Sylvan Baca MD PhD (Hiring!) avatar
Sylvan Baca MD PhD (Hiring!)@SylvanBacaLab·Oct 29

We found thousands of cell-free chromatin QTLs (cfcQTLs): sites where inherited variants are associated with regulatory element activity. Chromatin from cancer provided access to a broad range of regulatory elements not detectable in blood cells.

Post attachment
Sylvan Baca MD PhD (Hiring!) avatar
Sylvan Baca MD PhD (Hiring!)@SylvanBacaLab·Oct 29

We analyzed circulating chromatin from >300 patients with cancer. Using cfChIP-seq, we measured histone marks associated with active promoters and enhancers. Germline genotypes imputed from cfChIP-seq reads let us tie genetic variation to differences in histone mark signal.

Post attachment
Sylvan Baca MD PhD (Hiring!) avatar
Sylvan Baca MD PhD (Hiring!)@SylvanBacaLab·Oct 29

Blood plasma contains chromatin shed from a wide range of cell types, especially in patients with advanced cancers. We asked if chromatin circulating in blood can report on gene regulation in cell types that are hard to sample.

Sylvan Baca MD PhD (Hiring!) avatar
Sylvan Baca MD PhD (Hiring!)@SylvanBacaLab·Oct 29

Many risk variants identified by genome-wide association studies (GWAS) affect regulatory DNA. Understanding how these variants work requires measuring gene regulation in the relevant cell types - not easy in vivo.

Sylvan Baca MD PhD (Hiring!) avatar
Sylvan Baca MD PhD (Hiring!)@SylvanBacaLab·Oct 29

Inspiring to watch cancer centers + industry come together to enable large-scale federated machine learning in oncology. We're working with @CAIAorg to predict lineage plasticity in prostate cancer - cross-institutional validation and scale make all the difference here!

Post attachment
3:44